CrushSCI.com
52.7Average days
52Median days
1Fastest days
102Longest days
1172025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

69 days

Prevalence and Characteristics of Potential QT ‐Interval‐Prolonging Drug–Drug Interactions in Patients Receiving Oral Anticancer Drugs

Authors
Fatimah Alhurayri; Islam R. Younis; Shadia I. Jalal; Theodore F. Logan; Rohan Maniar; Steven M. Bray; Sara K. Quinney; Zeruesenay Desta; Todd C. Skaar; James E. Tisdale; Tyler ShuggShow moreShow less
Affiliations
1. Department of Pharmacy Practice Purdue University College of Pharmacy West Lafayette Indiana USA; 2. College of Pharmacy Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia; 3. Department of Quantitative Pharmacology & Pharmacometrics Merck & Co. Rahway New Jersey USA; 4. Division of Hematology/Oncology, Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA; 5. Fountain Life, Inc. Indianapolis Indiana USA; 6. Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine Indianapolis Indiana USAShow moreShow less
Source PDF DOI Publisher page
45 days

Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti‐Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists

Authors
Erin F. Barreto; Erin K. McCreary; Rekha Pai Mangalore; Sonya Tang Girdwood; Rebecca Arriola; Cynthia Bens; Robert A. Bonomo; Andrea N. Edginton; Lisa T. Hong; Angela Huttner; Birgit C. P. Koch; Nicole Maranchick; Michael N. Neely; Charles R. Peloquin; Gauri G. Rao; Jason A. Roberts; Anka C. Röhr; Marc H. Scheetz; Audrey N. Schuetz; Paul R. Yarnold; Andres Zuluaga; Nathaniel J. RhodesShow moreShow less
Affiliations
1. Department of Pharmacy Mayo Clinic Rochester Minnesota USA; 2. Department of Medicine, Division of Infectious Diseases University of Pittsburgh Pittsburgh Pennsylvania USA; 3. Department of Infectious Diseases, The Alfred Hospital, Bayside Health, Melbourne and School of Translational Medicine & Centre to Impact AMR Monash University Melbourne Victoria Australia; 4. Divisions of Hospital Medicine and Translational and Clinical Pharmacology Cincinnati Children’s Hospital Medical Center Cincinnati Ohio USA; 5. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio USA; 6. Pharmacometrics Center of Excellence Midwestern University, Downers Grove Campus Downers Grove Illinois USA; 7. Personalized Medicine Coalition Washington DC USA; 8. Cleveland VAMC Cleveland Ohio USA; 9. Case VA Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland Ohio USA; 10. School of Pharmacy University of Waterloo Waterloo Ontario Canada; 11. Loma Linda University School of Pharmacy Loma Linda California USA; 12. Division of Infectious Diseases Geneva University Hospitals and Faculty of Medicine Geneva Switzerland; 13. Department of Hospital Pharmacy Erasmus MC, University Medical Center Rotterdam the Netherlands; 14. Department of Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen Groningen the Netherlands; 15. Department of Pharmacotherapy & Translational Research University of Florida College of Pharmacy Gainesville Florida USA; 16. Children’s Hospital Los Angeles, Keck School of Medicine University of Southern California Los Angeles California USA; 17. University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences Los Angeles California USA; 18. University of Queensland Centre for Clinical Research, Faculty of Health Medicine and Behavioural Sciences the University of Queensland Brisbane Queensland Australia; 19. Herston Infectious Diseases Institute (HeIDI), Metro North Health Brisbane Queensland Australia; 20. Department of Pharmacy and Intensive Care Medicine Royal Brisbane and Women’s Hospital Brisbane Queensland Australia; 21. UR UM 103, University of Montpellier, Division of Anesthesia Critical Care and Emergency and Pain Medicine Nimes University Hospital Nimes France; 22. Department of Pharmacy General Hospital of Heidenheim Heidenheim Germany; 23. Department of Pharmacy Practice Midwestern University, Chicago College of Pharmacy Downers Grove Illinois USA; 24. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA; 25. Optimal Data Analysis, LLC Chicago Illinois USA; 26. Laboratorio Integrado de Medicina Especializada, Departamento de Farmacología y Toxicología Universidad de Antioquia Medellín ColombiaShow moreShow less
Source PDF DOI Publisher page
1 days

Women's Health in Oncology

Authors
Janelle PerkinsShow moreShow less
Affiliations
1. University of South Florida Taneja College of Pharmacy Tampa Florida USAShow moreShow less
Source PDF DOI Publisher page
102 days

Comparison of Bayesian and First‐Order Estimations of Vancomycin Area Under the Curve in Pediatrics Using One‐ and Two‐Concentration Methods

Authors
Katie B. Olney; Joo Eun Jun; David S. BurgessShow moreShow less
Affiliations
1. Department of Pharmacy Services University of Kentucky HealthCare Lexington Kentucky USA; 2. Department of Pharmacy Practice and Science University of Kentucky College of Pharmacy Lexington Kentucky USA; 3. University of Kentucky College of Pharmacy Lexington Kentucky USAShow moreShow less
Source PDF DOI Publisher page
59 days

A Data‐Driven Medication Regimen Complexity Score for Critically Ill Patients: MRC ‐ ICU 2.0

Authors
Bokai Zhao; Ye Shen; Kelli Henry; John W. Devlin; David J. Murphy; Susan E. Smith; Brian Murray; Sandra Rowe; Andrea SikoraShow moreShow less
Affiliations
1. University of Georgia College of Public Health, Epidemiology & Biostatistics Athens Georgia USA; 2. Department of Biomedical Informatics University of Colorado School of Medicine Aurora Colorado USA; 3. Northeastern University School of Pharmacy Boston Massachusetts USA; 4. Division of Pulmonary and Critical Care Medicine Brigham and Women's Hospital Boston Massachusetts USA; 5. Division of Pulmonary Sciences & Critical Care University of Colorado School of Medicine Aurora Colorado USA; 6. Department of Clinical and Administrative Pharmacy University of Georgia College of Pharmacy Athens Georgia USA; 7. Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora Colorado USA; 8. Oregon Health & Science University Portland Oregon USAShow moreShow less
Source PDF DOI Publisher page
40 days

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers

Authors
Owen Scudamore; Sven Wind; Rolf Grempler; Habib Esmaeili; Fabian MüllerShow moreShow less
Affiliations
1. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany; 2. Staburo GmbH Munich Germany; 3. Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does PHARMACOTHERAPY take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for PHARMACOTHERAPY. The fastest paper went from submission to acceptance in 1 days (Women's Health in Oncology, received 2026-07-05, accepted 2026-07-06); the slowest took 102 days. The average is 52.7 days and the median is 52 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.